How to Help Your Patients Find Acarbose in Stock: A Provider's Guide

Your patient has a valid prescription for acarbose and a confirmed diagnosis of type 2 diabetes — but their pharmacy doesn't have it. This scenario has become frustratingly common, and while acarbose is not in a formal FDA shortage in 2026, it is a low-volume generic that many pharmacies don't keep consistently on the shelf. Here's a practical provider's guide to helping your patients navigate this.

Why Does This Keep Happening?

Acarbose is prescribed far less frequently than other diabetes medications like metformin, SGLT2 inhibitors, or GLP-1 receptor agonists. Pharmacies operate on thin margins and make inventory decisions based on turnover rates. A drug that might be filled for only 2–3 patients per month at a given pharmacy is a candidate to be stocked on demand only — meaning your patient has to wait 1–2 days for the order to arrive, or go elsewhere.

Additionally, the discontinuation of brand-name Precose created a gap in how some pharmacy systems and insurance databases categorize acarbose, occasionally leading to "product not found" messages that aren't accurate.

Step 1: Write Prescriptions That Accommodate Substitution

When prescribing acarbose, consider adding a note on the prescription or in patient instructions that the pharmacy may need to special order it. If your state allows it, you can also authorize the pharmacist to contact you for equivalent-dose adjustments if a specific strength is unavailable. This reduces patient anxiety and unnecessary callbacks to your office.

Step 2: Recommend Specific Pharmacy Types

Not all pharmacies are created equal when it comes to stocking low-volume generics. At the point of prescribing, direct patients toward:

Walmart Pharmacy — carries a broad generic formulary at low prices; often stocks all three acarbose strengths

Costco Pharmacy — high-volume generic dispensing; open to non-members for pharmacy services

Mail-order pharmacies — Express Scripts, OptumRx, CVS Caremark, and Amazon Pharmacy maintain broader inventories; ideal for patients on stable long-term regimens with 90-day fills

Large hospital-affiliated outpatient pharmacies — often maintain full formularies and handle specialty orders routinely

Step 3: Refer Patients to medfinder

For patients who are struggling to find acarbose at a local pharmacy, medfinder is a practical referral. medfinder calls pharmacies near the patient's location to find which ones have the specific medication and strength in stock. The patient provides their drug, dose, and zip code; medfinder does the outreach and texts them confirmed results.

This keeps your front desk from being the call center for pharmacy availability questions and ensures patients get actionable information — not just a list of pharmacies to call themselves.

Step 4: Counsel Patients on Refill Timing

Because acarbose must be taken three times daily with meals, patients go through their supply faster than once-daily medications. Advise patients to request refills 5–7 days before they run out. If their pharmacy typically needs to special-order acarbose, building in that buffer prevents missed doses.

For patients who frequently run into stocking gaps, switching to a mail-order 90-day supply eliminates the monthly refill friction entirely.

Step 5: Have a Contingency Plan for Each Patient

For patients on acarbose, it's worth documenting in the chart — and communicating to the patient — what to do if their pharmacy is out. Options include:

Transfer the prescription to a larger chain pharmacy

Ask the pharmacy to special-order (typically 1–2 business days)

Use medfinder to identify a stocked pharmacy nearby

Brief bridge with dietary carbohydrate restriction if acarbose will only be missed for 1–2 days (discuss with patient)

When to Consider Therapeutic Substitution

If a patient is consistently unable to find acarbose over two or more refill cycles, it may be time to discuss a therapeutic alternative rather than continuing the search. The 2026 ADA Standards of Care and AACE algorithm both support individualized medication selection. For most patients who were on acarbose alone, a DPP-4 inhibitor or low-dose metformin may provide similar or superior glycemic control with better pharmacy access.

See also: Acarbose Shortage: What Providers and Prescribers Need to Know in 2026